SREBF1 and hepatocellular carcinoma: A small-molecule inhibitor of SREBP-1, SI-1, 1-(4-bromophenyl)-3-(pyridin-3-yl) urea, inhibits aerobic glycolysis, increases killing of HCC cells by radiofrequency ablation, and slows the growth of xenograft tumors.